← All companies

SLGL

Sol-Gel Technologies Ltd.

SLGL Nasdaq Pharmaceutical Preparations EDGAR ↗

$81.99

-3.20 -3.76%

Key statistics

from XBRL data in SEC filings

Market cap

$228M

Revenue (TTM)

$19.4M

Net income (TTM)

-$6.13M

EPS (TTM)

$-2.19

P/E ratio

—

Dividend yield

—

Free cash flow

$275K

Cash

$11.0M

Total assets

$29.9M

Gross margin

—

52-week range

$12.66 – $97.97

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K May 28, 2026 6-K Mar 24, 2026 20-F Mar 19, 2026 6-K Dec 17, 2025 6-K Nov 20, 2025 6-K Nov 14, 2025 6-K Sep 25, 2025 6-K Sep 4, 2025 6-K Aug 15, 2025 6-K May 23, 2025 6-K May 22, 2025 6-K/A 6-K May 8, 2025 6-K May 5, 2025 20-F Apr 29, 2025 6-K Apr 17, 2025 6-K Apr 1, 2025 6-K Feb 18, 2025 6-K Nov 20, 2024 6-K Nov 15, 2024 6-K Nov 4, 2024 6-K Sep 25, 2024 6-K Aug 27, 2024 6-K/A Aug 19, 2024 6-K Aug 16, 2024 6-K Jul 25, 2024 6-K Jul 22, 2024 6-K Jul 15, 2024 6-K May 28, 2024 6-K May 20, 2024 6-K May 16, 2024 6-K Apr 1, 2024 20-F Mar 13, 2024 6-K Mar 13, 2024 6-K Mar 6, 2024 6-K Feb 29, 2024 6-K Jan 23, 2024 6-K Jan 17, 2024 6-K Nov 30, 2023 6-K Nov 20, 2023 6-K Nov 9, 2023